Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 1
1999 1
2002 1
2003 2
2006 2
2007 3
2008 2
2011 2
2012 3
2014 1
2015 2
2018 2
2019 2
2020 3
2021 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Cervical cancer.
Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, Bodurka DC. Basen-Engquist K, et al. Among authors: wenzel lb. Cancer. 2003 Nov 1;98(9 Suppl):2009-14. doi: 10.1002/cncr.11681. Cancer. 2003. PMID: 14603537 Free article. Review.
Survivorship as an element of clinical trials in ovarian cancer.
McAlpine JN, Wenzel LB; Gynecologic Cancer InterGroup. McAlpine JN, et al. Among authors: wenzel lb. Int J Gynecol Cancer. 2011 May;21(4):788-92. doi: 10.1097/IGC.0b013e31821bb717. Int J Gynecol Cancer. 2011. PMID: 21543942 Free PMC article. Review. No abstract available.
Supportive care for women with gynecologic cancers.
Chase DM, Monk BJ, Wenzel LB, Tewari KS. Chase DM, et al. Among authors: wenzel lb. Expert Rev Anticancer Ther. 2008 Feb;8(2):227-41. doi: 10.1586/14737140.8.2.227. Expert Rev Anticancer Ther. 2008. PMID: 18279064 Free article. Review.
GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function.
Carter J, Huang HQ, Armer J, Carlson JW, Lockwood S, Nolte S, Kauderer J, Hutson A, Walker JL, Fleury AC, Bonebrake A, Soper JT, Mathews C, Zivanovic O, Richards WE, Tan A, Alberts DS, Barakat RR, Wenzel LB. Carter J, et al. Among authors: wenzel lb. Gynecol Oncol. 2021 Jan;160(1):244-251. doi: 10.1016/j.ygyno.2020.10.023. Epub 2020 Oct 24. Gynecol Oncol. 2021. PMID: 33109392 Free PMC article. Review.
Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.
Matulonis UA, Huang HQ, Filiaci VL, Randall M, DiSilvestro PA, Moxley KM, Fowler JM, Powell MA, Spirtos NM, Tewari KS, Richards WE, Nakayama JM, Mutch DG, Miller DS, Matei D, Wenzel LB. Matulonis UA, et al. Among authors: wenzel lb. Gynecol Oncol. 2022 Feb;164(2):428-436. doi: 10.1016/j.ygyno.2021.11.021. Epub 2021 Dec 11. Gynecol Oncol. 2022. PMID: 34903380 Free PMC article. Clinical Trial.
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259).
Donovan HS, Sereika SM, Wenzel LB, Edwards RP, Knapp JE, Hughes SH, Roberge MC, Thomas TH, Klein SJ, Spring MB, Nolte S, Landrum LM, Casey AC, Mutch DG, DeBernardo RL, Muller CY, Sullivan SA, Ward SE. Donovan HS, et al. Among authors: wenzel lb. J Clin Oncol. 2022 May 1;40(13):1464-1473. doi: 10.1200/JCO.21.00656. Epub 2022 Feb 7. J Clin Oncol. 2022. PMID: 35130043 Free PMC article. Clinical Trial.
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study.
Chase D, Huang HQ, Monk BJ, Ramondetta LM, Penson RT, Gil K, Landrum LM, Leitao M, Oaknin A, Huh WK, Pulaski HL, Robison K, Guntupalli SR, Richardson D, Salani R, Sill MW, Wenzel LB, Tewari KS. Chase D, et al. Among authors: wenzel lb. Int J Gynecol Cancer. 2020 May;30(5):596-601. doi: 10.1136/ijgc-2019-000869. Epub 2020 Feb 28. Int J Gynecol Cancer. 2020. PMID: 32114513 Free PMC article. Clinical Trial.
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial.
Friedlander M, Gebski V, Gibbs E, Davies L, Bloomfield R, Hilpert F, Wenzel LB, Eek D, Rodrigues M, Clamp A, Penson RT, Provencher D, Korach J, Huzarski T, Vidal L, Salutari V, Scott C, Nicoletto MO, Tamura K, Espinoza D, Joly F, Pujade-Lauraine E. Friedlander M, et al. Among authors: wenzel lb. Lancet Oncol. 2018 Aug;19(8):1126-1134. doi: 10.1016/S1470-2045(18)30343-7. Epub 2018 Jul 17. Lancet Oncol. 2018. PMID: 30026002 Free PMC article. Clinical Trial.
27 results